Enhancing Plasticity of the Central Nervous System: Drugs, Stem Cell Therapy, and Neuro-Implants

Neural Plasticity

Volumn 2017, Issue , 2017, Pages

  Le Friec, Alice ^a   Salabert, Anne Sophie ^a,b   Davoust, Carole ^a   Demain, Boris ^a   Vieu, Christophe ^a,b   Vaysse, Laurence ^a   Payoux, Pierre ^a   Loubinoux, Isabelle ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BIOMATERIAL; BIOMIMETIC MATERIAL; BRAIN DERIVED NEUROTROPHIC FACTOR; CITALOPRAM; COPOLYMER; FIBROBLAST GROWTH FACTOR 2; FLUOXETINE; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; MYELIN ASSOCIATED GLYCOPROTEIN; NANOFIBER; POLYGLYCOLIC ACID; POLYLACTIC ACID; POLYLYSINE; PROTEIN NOGO; REFANEZUMAB; SEROTONIN UPTAKE INHIBITOR; TAMOXIFEN; TRACER; TRAFERMIN; NEUROPROTECTIVE AGENT;

BRAIN DAMAGE; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR ACCIDENT; DEPRESSION; ENGRAFTMENT; HUMAN; HYDROGEL; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NERVE CELL PLASTICITY; NERVE REGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; OLFACTORY ENSHEATHING CELL; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); POSITRON EMISSION TOMOGRAPHY; RANKIN SCALE; REVIEW; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; SPINAL CORD INJURY; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; X-RAY COMPUTED TOMOGRAPHY; ANIMAL; BRAIN; CONVALESCENCE; DRUG EFFECT; NANOTECHNOLOGY; PATHOLOGY; PROCEDURES; STROKE REHABILITATION;

ANIMALS; BIOCOMPATIBLE MATERIALS; BRAIN; HUMANS; NANOTECHNOLOGY; NEURONAL PLASTICITY; NEUROPROTECTIVE AGENTS; RECOVERY OF FUNCTION; STEM CELL TRANSPLANTATION; STROKE; STROKE REHABILITATION;

EID: 85042410456     PISSN: 20905904     EISSN: 16875443     Source Type: Journal    
DOI: 10.1155/2017/2545736     Document Type: Review

References (80)

1. O. Lindvall and Z. Kokaia, "Neurogenesis following stroke affecting the adult brain, " Cold Spring Harbor Perspectives in Biology, vol. 7, no. 11, article a019034, 2015.
2. T. H. Murphy and D. Corbett, "Plasticity during stroke recovery: From synapse to behaviour, " Nature Reviews Neuroscience, vol. 10, no. 12, pp. 861-872, 2009.
3. K. Jin, X. Wang, L. Xie, et al., "Evidence for stroke-induced neurogenesis in the human brain, " Proceedings of the National Academy of Sciences, vol. 103, no. 35, pp. 13198-13202, 2006.
4. D. M. Hermann and M. Chopp, "Promoting brain remodelling and plasticity for stroke recovery: Therapeutic promise and potential pitfalls of clinical translation, " Lancet Neurology, vol. 11, no. 4, pp. 369-380, 2012.
5. C. Grefkes and G. R. Fink, "Connectivity-based approaches in stroke and recovery of function, " Lancet Neurology, vol. 13, no. 2, pp. 206-216, 2014.
6. H. Liu, T. Tian, W. Qin, K. Li, C. Yu, "Contrasting evolutionary patterns of functional connectivity in sensorimotor and cognitive regions after stroke, " Frontiers in Behavioral Neuroscience, vol. 10, p. 72, 2016.
7. C. Alia, C. Spalletti, S. Lai, A. Panarese, S. Micera, M. Caleo, "Reducing GABAA-mediated inhibition improves forelimb motor function after focal cortical stroke in mice, " Scientific Reports, vol. 6, no. 1, article 37823, 2016.
8. F. Chollet, J. Tardy, J.-F. Albucher, et al., "Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): A randomised placebo-controlled trial, " Lancet Neurology, vol. 10, no. 2, pp. 123-130, 2011.
9. A. Arvidsson, T. Collin, D. Kirik, Z. Kokaia, O. Lindvall, "Neuronal replacement from endogenous precursors in the adult brain after stroke, " Nature Medicine, vol. 8, no. 9, pp. 963-970, 2002.
10. V. C. Muñetón-Gómez, E. Doncel-Pérez, A. P. Fernandez, et al., "Neural differentiation of transplanted neural stem cells in a rat model of striatal lacunar infarction: Light and electron microscopic observations, " Frontiers in Cellular Neuroscience, vol. 6, 2012.
11. L. Vaysse, F. Conchou, B. Demain, et al., "Strength and fine dexterity recovery profiles after a primary motor cortex insult and effect of a neuronal cell graft, " Behavioral Neuroscience, vol. 129, no. 4, pp. 423-434, 2015.
12. J. Yamane, M. Nakamura, A. Iwanami, et al., "Transplantation of galectin-1-expressing human neural stem cells into the injured spinal cord of adult common marmosets, " Journal of Neuroscience Research, vol. 88, no. 7, pp. 1394-1405, 2010.
13. G. K. Steinberg, D. Kondziolka, L. R. Wechsler, et al., "Clinical outcomes of transplanted modified bone marrow-derived mesenchymal stem cells in stroke: A phase 1/2a study, " Stroke, vol. 47, no. 7, pp. 1817-1824, 2016.
14. D. Kalladka, J. Sinden, K. Pollock, et al., "Human neural stem cells in patients with chronic ischaemic stroke (PISCES): A phase 1, first-in-man study, " The Lancet, vol. 388, no. 10046, pp. 787-796, 2016.
15. D. J. Kota, K. S. Prabhakara, A. J. van Brummen, et al., "Propranolol and mesenchymal stromal cells combine to treat traumatic brain injury, " Stem Cells Translational Medicine, vol. 5, no. 1, pp. 33-44, 2016.
16. C. S. Cox Jr., R. A. Hetz, G. P. Liao, et al., "Treatment of severe adult traumatic brain injury using bone marrow mononuclear cells, " Stem Cells, vol. 35, no. 4, pp. 1065-1079, 2017.
17. P. Tabakow, W. Jarmundowicz, B. Czapiga, et al., "Transplantation of autologous olfactory ensheathing cells in complete human spinal cord injury, " Cell Transplantation, vol. 22, no. 9, pp. 1591-1612, 2013.
18. G. B. Boncoraglio, A. Bersano, L. Candelise, B. A. Reynolds, E. A. Parati, "Stem cell transplantation for ischemic stroke, " Cochrane Database of Systematic Reviews, vol. 9, article CD007231, 2010.
19. J. E. Burda and M. V. Sofroniew, "Reactive gliosis and the multicellular response to CNS damage and disease, " Neuron, vol. 81, no. 2, pp. 229-248, 2014.
20. T. M. Coyne, A. J. Marcus, D. Woodbury, I. B. Black, "Marrow stromal cells transplanted to the adult brain are rejected by an inflammatory response and transfer donor labels to host neurons and glia, " Stem Cells, vol. 24, no. 11, pp. 2483-2492, 2006.
21. A. Jablonska, M. Janowski, B. Lukomska, "Different methods of immunosuppresion do not prolong the survival of human cord blood-derived neural stem cells transplanted into focal brain-injured immunocompetent rats, " Acta Neurobiologiae Experimentalis, vol. 73, no. 1, pp. 88-101, 2013.
22. L. S. B. Boisserand, T. Kodama, J. Papassin, et al., "Biomaterial applications in cell-based therapy in experimental stroke, " Stem Cells International, vol. 2016, Article ID 6810562, 14 pages, 2016.
23. H. Ghuman, A. R. Massensini, J. Donnelly, et al., "ECM hydrogel for the treatment of stroke: Characterization of the host cell infiltrate, " Biomaterials, vol. 91, pp. 166-181, 2016.
24. D. F. Emerich, E. Silva, O. Ali, et al., "Injectable VEGF hydrogels produce near complete neurological and anatomical protection following cerebral ischemia in rats, " Cell Transplantation, vol. 19, no. 9, pp. 1063-1071, 2010.
25. A. Béduer, C. Vieu, F. Arnauduc, J.-C. Sol, I. Loubinoux, L. Vaysse, "Engineering of adult human neural stem cells differentiation through surface micropatterning, " Biomaterials, vol. 33, no. 2, pp. 504-514, 2012.
26. N. Theodore, R. Hlubek, J. Danielson, et al., "First human implantation of a bioresorbable polymer scaffold for acute traumatic spinal cord injury: A clinical pilot study for safety and feasibility, " Neurosurgery, vol. 79, no. 2, pp. E305-E312, 2016.
27. E. Bible, F. Dell'Acqua, B. Solanky, et al., "Non-invasive imaging of transplanted human neural stem cells and ECM scaffold remodeling in the stroke-damaged rat brain by 19F-A nd diffusion-MRI, " Biomaterials, vol. 33, no. 10, pp. 2858-2871, 2012.
28. P. Moshayedi, L. R. Nih, I. L. Llorente, et al., "Systematic optimization of an engineered hydrogel allows for selective control of human neural stem cell survival and differentiation after transplantation in the stroke brain, " Biomaterials, vol. 105, pp. 145-155, 2016.
29. S. C. Cramer, B. Abila, N. E. Scott, M. Simeoni, L. A. Enney, on behalf of the MAG111539 Study Investigators, "Safety, pharmacokinetics, pharmacodynamics of escalating repeat doses of GSK249320 in patients with stroke, " Stroke, vol. 44, no. 5, pp. 1337-1342, 2013.
30. D. Cash, A. C. Easton, M. Mesquita, et al., "GSK249320, a monoclonal antibody against the axon outgrowth inhibition molecule myelin-associated glycoprotein, improves outcome of rodents with experimental stroke, " Journal of Neurology and Experimental Neuroscience, vol. 2, no. 2, pp. 28-33, 2016.
31. S. C. Cramer, L. A. Enney, C. K. Russell, M. Simeoni, T. R. Thompson, "Proof-of-concept randomized trial of the monoclonal antibody GSK249320 versus placebo in stroke patients, " Stroke, vol. 48, no. 3, pp. 692-698, 2017.
32. K. Abe, T. Yamashita, S. Takizawa, S. Kuroda, H. Kinouchi, N. Kawahara, "Stem cell therapy for cerebral ischemia: From basic science to clinical applications, " Journal of Cerebral Blood Flow & Metabolism, vol. 32, no. 7, pp. 1317-1331, 2012.
33. P. M. Bath, N. Sprigg, T. England, "Colony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke, " Cochrane Database of Systematic Reviews, vol. 12, article CD005207, 2013.
34. J. Bogousslavsky, S. J. Victor, E. O. Salinas, et al., "Fiblast (trafermin) in acute stroke: Results of the European-Australian phase II/III safety and efficacy trial, " Cerebrovascular Diseases, vol. 14, no. 3-4, pp. 239-251, 2002.
35. I. Loubinoux, "Correlation between cerebral reorganization and motor recovery after subcortical infarcts, " NeuroImage, vol. 20, no. 4, pp. 2166-2180, 2003.
36. D. Tombari, I. Loubinoux, J. Pariente, et al., "A longitudinal fMRI study: In recovering and then in clinically stable subcortical stroke patients, " NeuroImage, vol. 23, no. 3, pp. 827-839, 2004.
37. I. Loubinoux, S. Dechaumont-Palacin, E. Castel-Lacanal, et al., "Prognostic value of fMRI in recovery of hand function in subcortical stroke patients, " Cerebral Cortex, vol. 17, no. 12, pp. 2980-2987, 2007.
38. J. Pariente, I. Loubinoux, C. Carel, et al., "Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke, " Annals of Neurology, vol. 50, no. 6, pp. 718-729, 2001.
39. I. Loubinoux, J. Pariente, O. Rascol, P. Celsis, F. Chollet, "Selective serotonin reuptake inhibitor paroxetine modulates motor behavior through practice. A double-blind, placebocontrolled, multi-dose study in healthy subjects, " Neuropsychologia, vol. 40, no. 11, pp. 1815-1821, 2002.
40. I. Loubinoux, J. Pariente, K. Boulanouar, et al., "A single dose of the serotonin neurotransmission agonist paroxetine enhances motor output: Double-blind, placebo-controlled, fMRI study in healthy subjects, " NeuroImage, vol. 15, no. 1, pp. 26-36, 2002.
41. I. Loubinoux, D. Tombari, J. Pariente, et al., "Modulation of behavior and cortical motor activity in healthy subjects by a chronic administration of a serotonin enhancer, " NeuroImage, vol. 27, no. 2, pp. 299-313, 2005.
42. A. Gerdelat-Mas, I. Loubinoux, D. Tombari, O. Rascol, F. Chollet, M. Simonetta-Moreau, "Chronic administration of selective serotonin reuptake inhibitor (SSRI) paroxetine modulates human motor cortex excitability in healthy subjects, " NeuroImage, vol. 27, no. 2, pp. 314-322, 2005.
43. I. Loubinoux and F. Chollet, "Neuropharmacology in stroke recovery, " in Brain Repair Stroke, Cambridge University Press, Cambridge, 2010.
44. J. Tardy, J. Pariente, A. Leger, et al., "Methylphenidate modulates cerebral post-stroke reorganization, " NeuroImage, vol. 33, no. 3, pp. 913-922, 2006.
45. F. Chollet, "Fluoxetine and motor recovery after ischaemic stroke-author's reply, " Lancet Neurology, vol. 10, no. 6, pp. 500-501, 2011.
46. D. Savadi Oskouie, E. Sharifipour, H. Sadeghi Bazargani, et al., "Efficacy of citalopram on acute ischemic stroke outcome: A randomized clinical trial, " Neurorehabilitation and Neural Repair, vol. 31, no. 7, pp. 638-647, 2017.
47. F. Chollet, S. C. Cramer, C. Stinear, et al., "Pharmacological therapies in post stroke recovery: Recommendations for future clinical trials, " Journal of Neurology, vol. 261, no. 8, pp. 1461-1468, 2014.
48. G. Mead, C. Hsieh, R. Lee, et al., "Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery, " Cochrane Database of Systematic Reviews, vol. 11, article CD009286, 2012.
49. G. Mead, M. L. Hackett, E. Lundström, V. Murray, G. J. Hankey, M. Dennis, "The FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: A study protocol for three multicentre randomised controlled trials, " Trials, vol. 16, no. 1, p. 369, 2015.
50. B. L. Jacobs and C. A. Fornal, "Serotonin and motor activity, " Current Opinion in Neurobiology, vol. 7, no. 6, pp. 820-825, 1997.
51. C.-M. Lim, S.-W. Kim, J.-Y. Park, C. Kim, S. H. Yoon, J.-K. Lee, "Fluoxetine affords robust neuroprotection in the postischemic brain via its anti-inflammatory effect, " Journal of Neuroscience Research, vol. 87, no. 4, pp. 1037-1045, 2009.
52. J. Y. Lee, H. E. Lee, S. R. Kang, H. Y. Choi, J. H. Ryu, T. Y. Yune, "Fluoxetine inhibits transient global ischemia-induced hippocampal neuronal death and memory impairment by preventing blood-brain barrier disruption, " Neuropharmacology, vol. 79, pp. 161-171, 2014.
53. C. H. Lee, J. H. Park, K.-Y. Yoo, et al., "Pre-A nd posttreatments with escitalopram protect against experimental ischemic neuronal damage via regulation of BDNF expression and oxidative stress, " Experimental Neurology, vol. 229, no. 2, pp. 450-459, 2011.
54. W.-L. Li, H.-H. Cai, B. Wang, et al., "Chronic fluoxetine treatment improves ischemia-induced spatial cognitive deficits through increasing hippocampal neurogenesis after stroke, " Journal of Neuroscience Research, vol. 87, no. 1, pp. 112-122, 2009.
55. N. Taguchi, S. Nakayama, M. Tanaka, "Fluoxetine has neuroprotective effects after cardiac arrest and cardiopulmonary resuscitation in mouse, " Resuscitation, vol. 83, no. 5, pp. 652-656, 2012.
56. A.-M. Buga, O. Ciobanu, G. M. Bdescu, et al., "Up-regulation of serotonin receptor 2B mRNA and protein in the periinfarcted area of aged rats and stroke patients, " Oncotarget, vol. 7, no. 14, pp. 17415-17430, 2016.
57. L. Santarelli, M. Saxe, C. Gross, et al., "Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants, " Science, vol. 301, no. 5634, pp. 805-809, 2003.
58. E. Vermetten, M. Vythilingam, S. M. Southwick, D. S. Charney, J. D. Bremner, "Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder, " Biological Psychiatry, vol. 54, no. 7, pp. 693-702, 2003.
59. P. S. Eriksson, E. Perfilieva, T. Björk-Eriksson, et al., "Neurogenesis in the adult human hippocampus, " Nature Medicine, vol. 4, no. 11, pp. 1313-1317, 1998.
60. J. Chen, S. S. P. Magavi, J. D. Macklis, "Neurogenesis of corticospinal motor neurons extending spinal projections in adult mice, " Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 46, pp. 16357-16362, 2004.
61. S. S. Magavi, B. R. Leavitt, J. D. Macklis, "Induction of neurogenesis in the neocortex of adult mice, " Nature, vol. 405, no. 6789, pp. 951-955, 2000.
62. M. Dihne, H.-P. Hartung, R. J. Seitz, "Restoring neuronal function after stroke by cell replacement: Anatomic and functional considerations, " Stroke, vol. 42, no. 8, pp. 2342-2350, 2011.
63. Y. Li, K. McIntosh, J. Chen, et al., "Allogeneic bone marrow stromal cells promote glial-axonal remodeling without immunologic sensitization after stroke in rats, " Experimental Neurology, vol. 198, no. 2, pp. 313-325, 2006.
64. J. S. Lee, J. M. Hong, G. J. Moon, P. H. Lee, Y. H. Ahn, O. Y. Bang, "A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke, " Stem Cells, vol. 28, no. 6, pp. 1099-1106, 2010.
65. L. Chen, G. Zhang, A. A. Khan, X. Guo, Y. Gu, "Clinical efficacy and meta-analysis of stem cell therapies for patients with brain ischemia, " Stem Cells International, vol. 2016, Article ID 6129579, 8 pages, 2016.
66. K. Prasad, A. Sharma, A. Garg, et al., "Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke, " Stroke, vol. 45, no. 12, pp. 3618-3624, 2014.
67. D. C. Hess, L. R. Wechsler, W. M. Clark, et al., "Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): A randomised, double-blind, placebo-controlled, phase 2 trial, " Lancet Neurology, vol. 16, no. 5, pp. 360-368, 2017.
68. D. Kondziolka, G. K. Steinberg, L. Wechsler, et al., "Neurotransplantation for patients with subcortical motor stroke: A phase 2 randomized trial, " Journal of Neurosurgery, vol. 103, no. 1, pp. 38-45, 2005.
69. D. Kondziolka, L. Wechsler, S. Goldstein, et al., "Transplantation of cultured human neuronal cells for patients with stroke, " Neurology, vol. 55, no. 4, pp. 565-569, 2000.
70. C. S. Stilley, C. M. Ryan, D. Kondziolka, A. Bender, S. DeCesare, L. Wechsler, "Changes in cognitive function after neuronal cell transplantation for basal ganglia stroke, " Neurology, vol. 63, no. 7, pp. 1320-1322, 2004.
71. J. Silver and J. H. Miller, "Regeneration beyond the glial scar, " Nature Reviews Neuroscience, vol. 5, no. 2, pp. 146-156, 2004.
72. V. M. Tysseling-Mattiace, V. Sahni, K. L. Niece, et al., "Selfassembling nanofibers inhibit glial scar formation and promote axon elongation after spinal cord injury, " The Journal of Neuroscience, vol. 28, no. 14, pp. 3814-3823, 2008.
73. J. R. Slotkin, C. D. Pritchard, B. Luque, et al., "Biodegradable scaffolds promote tissue remodeling and functional improvement in non-human primates with acute spinal cord injury, " Biomaterials, vol. 123, pp. 63-76, 2017.
74. K. I. Park, Y. D. Teng, E. Y. Snyder, "The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue, " Nature Biotechnology, vol. 20, no. 11, pp. 1111-1117, 2002.
75. K. Jin, X. Mao, L. Xie, et al., "Transplantation of human neural precursor cells in Matrigel scaffolding improves outcome from focal cerebral ischemia after delayed postischemic treatment in rats, " Journal of Cerebral Blood Flow & Metabolism, vol. 30, no. 3, pp. 534-544, 2010.
76. G. J.-R. Delcroix, E. Garbayo, L. Sindji, et al., "The therapeutic potential of human multipotent mesenchymal stromal cells combined with pharmacologically active microcarriers transplanted in hemi-parkinsonian rats, " Biomaterials, vol. 32, no. 6, pp. 1560-1573, 2011.
77. L. Vaysse, A. Beduer, J. C. Sol, C. Vieu, I. Loubinoux, "Micropatterned bioimplant with guided neuronal cells to promote tissue reconstruction and improve functional recovery after primary motor cortex insult, " Biomaterials, vol. 58, pp. 46-53, 2015.
78. L. Vaysse, C. Labie, B. Canolle, et al., "Adult human progenitor cells from the temporal lobe: Another source of neuronal cells, " Brain Injury, vol. 26, no. 13-14, pp. 1636-1645, 2012.
79. F. Tensaouti and J. A. Lotterie, "Sysiphe-Neuroimaging software toolbox, " in European Society for Magnetic Resonance Medicine and Biology 2008 Congress, pp. 2-4, Springer, Berlin, 2008.
80. Z. Álvarez, O. Castanõ, A. A. Castells, et al., "Neurogenesis and vascularization of the damaged brain using a lactate-releasing biomimetic scaffold, " Biomaterials, vol. 35, no. 17, pp. 4769-4781, 2014.